Aurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid Disclosure
Aurora Cannabis has asked Alberta’s securities regulator to review alleged deficiencies in Curaleaf’s disclosure for its hostile bid. The filing creates a regulatory hurdle for Curaleaf’s offer and puts the adequacy of the bid materials before the commission.
Aurora Cannabis said it has applied to the Alberta Securities Commission for an order requiring Curaleaf to comply with securities laws in connection with Curaleaf’s hostile bid. Aurora intends to argue that Curaleaf’s circular contains several deficiencies affecting Aurora shareholders.
The dispute moves the takeover contest beyond direct shareholder solicitation and into securities-law review. The application concerns the bid’s disclosure materials, rather than the operating performance of Aurora’s cannabis business.
Aurora is the company seeking regulatory relief, while Curaleaf is the bidder whose circular is being challenged. The concrete mechanism is the Alberta commission’s ability to require compliance with applicable disclosure requirements before the bid process can proceed on its current footing.
The extent of the alleged deficiencies and the regulator’s response are not established here. The next developments are the Alberta Securities Commission’s handling of the application and any resulting order or timetable affecting Curaleaf’s circular and hostile bid.
Aurora Cannabis (ACB) asked Alberta’s regulator to review alleged deficiencies in Curaleaf’s hostile-bid circular.
The immediate consequence is procedural: a regulator could require changes to Curaleaf’s circular, extending uncertainty around the bid without yet changing Aurora’s operations. Aurora’s older financial profile—$221.3M in revenue, down 9.8% year over year, and a -776.2% net margin—makes the takeover process material, but those figures do not resolve the disclosure dispute.
The Alberta Securities Commission may reject the application or allow the bid to proceed without requiring material changes to Curaleaf’s circular.
CoverageSource: PR Newswire · Published here WED, SEP 23 · 6:28 PM ET · the only report in this recordHow this is decided →
PR NEWSWIRE / FILEEarlier context and later coverage are dated relative to this report. Automatically linked reports may cover a broader event.
No later reports linked yet.
Follow this story to find new evidence in your Following desk.
Aurora’s application could force corrective disclosure or delay Curaleaf’s hostile bid, giving shareholders more information before deciding on the offer.
The case for a stronger read is limited because no regulatory order has been issued and the alleged disclosure deficiencies are not detailed here.
Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →